首页>
外国专利>
ORAL PREPARATION FOR PROMOTING EXPRESSION OF TGF-β, ORAL PREPARATION FOR INHIBITING PRODUCTION OF PAIN-MEDIATING SUBSTANCE, AND ORAL PREPARATION FOR PREVENTING EDEMA
ORAL PREPARATION FOR PROMOTING EXPRESSION OF TGF-β, ORAL PREPARATION FOR INHIBITING PRODUCTION OF PAIN-MEDIATING SUBSTANCE, AND ORAL PREPARATION FOR PREVENTING EDEMA
展开▼
机译:促进TGF-β表达的口服制剂,抑制疼痛介质的生产的口服制剂以及预防水肿的口服制剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
An oral preparation for promoting the expression of TGF-β comprises hyaluronic acid or a pharmaceutically acceptable salt thereof as an active ingredient, and can promote the expression of TGF-β in plasma. An oral preparation for inhibiting the production of a pain-mediating substance comprises hyaluronic acid or a pharmaceutically acceptable salt thereof as an active ingredient, and can promote the expression of TGF-β in plasma to thereby inhibit the production of the pain-mediating substance. An oral preparation for inhibiting the production of a pain-mediating substance comprises hyaluronic acid or a pharmaceutically acceptable salt thereof as an active ingredient, and can inhibit the production of PGE2 and/or bradykinin which is a pain-mediating substance. An oral preparation for preventing edema comprises hyaluronic acid or a pharmaceutically acceptable salt thereof as an active ingredient, and can inhibit the production of PGE2 and/or bradykinin which is a pain-mediating substance.
展开▼